Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Sales |
2.57 |
1.01 |
2.39 |
2.45 |
3.06 |
Operating profit |
-13.64 |
-10.09 |
-6.87 |
-9.20 |
-8.08 |
Interest |
0.02 |
0.02 |
0.03 |
0.04 |
0.04 |
Gross profit |
-9.62 |
-6.18 |
-2.62 |
-3.17 |
-2.98 |
EPS (Rs) |
-0.51 |
-0.35 |
-0.14 |
-0.22 |
0.13 |
Quarterly
results in details
|
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Other income |
4.03 |
3.93 |
4.28 |
6.07 |
5.14 |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
5.20 |
4.69 |
3.46 |
4.32 |
4.21 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
4.18 |
6.19 |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
11.01 |
6.40 |
1.61 |
1.14 |
6.92 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
1.46 |
1.49 |
1.51 |
1.60 |
1.73 |
Taxation |
- |
- |
-1.00 |
- |
- |
Net profit / loss |
-11.07 |
-7.67 |
-3.12 |
-4.77 |
2.76 |
Extra ordinary item |
- |
- |
- |
- |
7.46 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
21.81 |
21.81 |
21.81 |
21.81 |
21.81 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-529.99 |
-1002.72 |
-287.99 |
-375.31 |
-263.92 |
GPM (%) |
-145.54 |
-125.17 |
-39.23 |
-37.20 |
-36.28 |
NPM (%) |
-167.56 |
-155.27 |
-46.85 |
-56.00 |
33.59 |